276 related articles for article (PubMed ID: 30533440)
1. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
4. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
[No Abstract] [Full Text] [Related]
5. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
Zhang C; Kosiorek HE; Patel BK; Pockaj BA; Ahmad SB; Cronin PA
Ann Surg Oncol; 2022 Oct; 29(10):6207-6212. PubMed ID: 35831526
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
8. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
[TBL] [Abstract][Full Text] [Related]
9. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
10. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
[TBL] [Abstract][Full Text] [Related]
11. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
12. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
Feliciano Y; Mamtani A; Morrow M; Stempel MM; Patil S; Jochelson MS
Ann Surg Oncol; 2017 Jun; 24(6):1492-1498. PubMed ID: 28058550
[TBL] [Abstract][Full Text] [Related]
13. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
Lee SC; Grant E; Sheth P; Garcia AA; Desai B; Ji L; Groshen S; Hwang D; Yamashita M; Hovanessian-Larsen L
J Ultrasound Med; 2017 May; 36(5):901-911. PubMed ID: 28150325
[TBL] [Abstract][Full Text] [Related]
15. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent.
Yim H; Ha T; Kang DK; Park SY; Jung Y; Kim TH
Acta Radiol; 2019 Feb; 60(2):131-139. PubMed ID: 29764199
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
[TBL] [Abstract][Full Text] [Related]
17. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of digital mammography, ultrasound and MRI in predicting the pathological complete response and residual tumor size of breast cancer after completion of neoadjuvant chemotherapy.
Sudhir R; Koppula VC; Rao TS; Sannapareddy K; Rajappa SJ; Murthy SS
Indian J Cancer; 2022; 59(3):345-353. PubMed ID: 33753611
[TBL] [Abstract][Full Text] [Related]
20. Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI.
Savaridas SL; Vinnicombe SJ; Warwick V; Evans A
Br J Radiol; 2023 Aug; 96(1148):20220921. PubMed ID: 37399083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
